Tidepath

Repair and recovery peptides

BPC-157

Also called Body Protection Compound 157

Based on a protein in stomach juice. Most of the evidence for it comes from animal and cell studies.

Status
Not approved by the FDA.
Routes we have on file
By injection or by mouth
Where doses come from
No checked dose range
Half-life
No measured half-life in people for injection under the skin in our sources

What it is

BPC-157 is a lab-made peptide based on part of a protein found in stomach juice. The evidence for the healing it's discussed for, in tendons, ligaments and the gut, comes mostly from animal and cell studies. There are a lot of those. There are very few in people.

What makes it distinct

Very little has been published on people: a 2026 systematic review found three small studies, with 30 people in all, none with a comparison group. The FDA says compounded BPC-157 (mixed from its ingredients by a pharmacist or doctor) may carry a risk of immune reactions (immunogenicity) when given by some routes, and may have complexities with impurities related to the peptide and with pinning down exactly what the active ingredient is. The FDA also says that, for the routes proposed, it has too little safety information to know whether BPC-157 would cause harm in people.

Open questions

  • Whether the animal and lab results hold up in people at all. Large human studies haven't answered it.
  • By mouth or by injection: both are reported, and no dose is established for either one.
  • How long it lasts in the body (pharmacokinetics). We found no measured half-life (the time it takes for half a dose to clear) in people for injection under the skin. Tidepath doesn't chart its levels.

More in Repair and recovery peptides